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Hematopoiesis in the embryo originates from mesodermal
cells and proceeds via a common precursor (hemangio-
blast) of endothelial cells and blood cells. Hemangioblasts
give rise to specialised endothelial cells (hemogenic
endothelium) which subsequently undergo a transition
into hematopoietic precursor cells. These cell fate deci-
sions are governed by lineage-specific transcription factors,
such as RUNX1, SCL/TAL1, FLI-1, PU.1 and C/EBP
family members. In our work we study how dynamic shifts
in the transcriptional regulatory network during this devel-
opmental pathway are regulated and how transcription
factors control the activation of hematopoietic genes. We
are also investigating, how these factors interact with each
other and with the chromatin landscape.
To this end, we measured the genome-wide dynamics
of chromatin alterations during the different steps of
formation of the hematopoietic system from mesodermal
cells using ES cell differentiation as model. We show that
the hematopoietic program is already primed in the
hemogenic endothelium as indicated by the binding of
SCL/TAL1, FLI-1, C/EBPb and enhancer-bound RNA-
Polymerase II as well as the appearance of DNAsel
hypersensitive sites. RUNX1 is absolutely required for the
transition from hemogenic endothelium cells into hema-
topoietic progenitors. To obtain mechanistic information
how this factor drives this process, we examined the
assembly of hematopoietic transcription factors on their
targets before and after this transition. Using an inducible
system, we show that after induction RUNX1 binds to
primed, but also novel elements and increases their his-
tone acetylation. Moreover, RUNX1 initiates rapid global
alterations in the binding patterns of SCL/TAL1 and
FLI1, involving both the extinction of binding sites as
well as the establishment of new sites. A significant frac-
tion of new elements bind SCL/TAL1 and FLI1 in close
proximity to RUNX1 in a pattern that is specific for
hematopoietic cells.
RUNX1 has previously shown to be expendable in
hematopoietic precursor cel l so n c et h e yh a v ef o r m e d
from the hemogenic endothelium. By precisely timed
withdrawal studies we show that immediately after
RUNX1 induction altered transcription factor complex
assembly at many genes is still reversible, but not at all
of them. Our experiments suggest a dynamic interplay
between RUNX1 and other transcription factors that
dictates the half-life of factor assemblies and their
dependency on RUNX1 and give a fascinating insight
into how a single master regulator shapes the epigenetic
landscape.
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